Copy
Counting down to launch day!

This update includes:
  • information how we have structured entities and shares
  • dates for the local roadshow around the Tairawhiti region
  • details of the online offer launch
  • when the Information Memorandum will be available
  • recent news coverage including our partnership with Rhizo Sciences
  • an update on the numbers of pre-registrations
  • links back to previous newsletters

Hikurangi Enterprises and our joint venture Hikurangi Bioactives Limited Partnership are offering local investors and supporters everywhere a chance to be a part of our story. 

We have been working with our lawyers, investment advisors and company directors to establish the investment company that locals and supporters around Aotearoa (and New Zealand citizens living overseas) will be able to buy shares in to progress a number of opportunities Hikurangi Enterprises and our partners have been developing.

This is a unique offer and unlike almost anything that has been done to date in New Zealand. We have a charitable trust (Hikurangi Huataukina Trust) wholly owning a charitable company (Hikurangi Enterprises Ltd) that both have economic development for the East Coast region as their purpose and created a joint venture with private investors (New Zealand Nutraceuticals Ltd) to form a Limited Partnership (Hikurangi Bioactives Limited Partnership). Hikurangi Bioactives has developed a business (Hikurangi Cannabis Company Limited) and is offering the community shares via Waiapu Investments Limited in a joint venture to co-own the medical cannabis company along with an institutional investor. Got it? Maybe this diagram will help... 



We've set up a page for Frequently Asked Questions on the Waiapu Investments and Hikurangi Cannabis Company offer. It includes links to a description of each of the entities/groups in the diagram above. if you have other queries, please email us or ask via the Hikurangi Medical Cannabis Collective page on Facebook

Waiapu Investments Limited has been established with a board we will introduce next week, along with the management team for Hikurangi Cannabis Company. All of the Intellectual Property, trade secrets, know-how, licenses, agreements and other assets pertaining to hemp and cannabis that have been held by Hikurangi Bioactives and Hikurangi Enterprises are being transferred to Hikurangi Cannabis Company Limited. This is where the value will reside and owned by shareholders in the respective entities. It may seem complicated on first read but the rationale for the structure is robust based on the interests of the various individuals and entities who have already or want to be invested in the New Zealand's first medical cannabis company. 

We'll be looking for an institutional partner with up to $4,000,000 to invest in Hikurangi Cannabis Company. If you know of someone who may be interested, they can contact Nick Sandlant at Northington Partners in Auckland.

The Waiapu Investments offer document (Information Memorandum) for interested investors will be released on 13 February on the Hikurangi Enterprises website and sent to all subscribers who have pre-registered.

A roadshow for local residents interested in investing with Waiapu Investments will travel around the Tairāwhiti/Gisborne region from 15-18 February. These events will provide an overview of the investment offer, details on the structure and the opportunity to buy shares at the event or to wait for the offer to be open  to all New Zealand citizens on 20 February. 

If you are planning to invest, we recommend saving time by registering an Investor Profile with PledgeMe here. Click here for a quick summary of how to register and invest with a PledgeMe equity raise.



KEY DATES:
13 Feb : Information Memorandum released via mailing list and website
15 Feb : Roadshow starts in Te Araroa (4-7pm)
16 Feb : Tikitiki (4-7pm)
17 Feb : Ruatorea (9am-12pm)
17 Feb : Tokomaru (2-5pm)
18 Feb : Uawa (9am-12pm)
18 Feb : Gisborne (2-5pm)
20 Feb : Online platform goes live on PledgeMe (7pm)
 

More big news.


Earlier this month we announced a new partnership with Seattle-based Rhizo Sciences to develop medical cannabis cultivation, extraction and manufacturing facilities for Hikurangi Cannabis. Their international experience and turnkey systems will enable Hikurangi Group to rapidly expand our Ruatoria medical cannabis cultivation operations and develop export manufacturing capability that meets the highest international standards for pharmaceutical grade products. 

Hikurangi Group and Rhizo Sciences intend to establish the first pharmaceutical grade GMP medical cannabis production and processing facility in New Zealand. This will allow Hikurangi Group to provide high quality medical cannabis products to New Zealand patients and become a leading producer and processor of medical cannabis internationally. You can read more about the plans here and look out next week for another major announcement!

 

Hikurangi Cannabis Company made national news featuring in the business sections of Radio NZ and Fairfax media and the local newspaper front page again this month along with two interviews on Radio Ngati Porou


Check out previous news stories and interviews here.


 

Thanks again for your interest in Hikurangi Enterprises and Waiapu Investments.
We now have over 1,500 people who have pre-registered for investing with Waiapu Investments and Hikurangi Cannabis Company. About 20% of those registered are from Gisborne/Tairāwhiti. More than half have indicated they might invest more than $1,000 and more than 30 are interested in investing over $50,000.

If you missed our previous updates, you can see them here: 
Investors Update #2: December 2017
Investors Update #1: November 2017
If you received this email directly from Hikurangi Enterprises then you're already on our mailing list. If you had it forwarded on from someone else, then you can sign up to receive future notices directly.
Sign Up
Copyright © 2018 Hikurangi Enterprises, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp